Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
NOT YET RECRUITING
NCT07409740
Optical Coherence Tomography Angiography Evaluation Of Patients Taking Hydroxychloroquine
Sponsor: Sohag University
View on ClinicalTrials.gov
Summary
This study aims to evaluate retinal and choroidal microvascular changes using optical coherence tomography angiography (OCTA) in patients receiving hydroxychloroquine therapy. Hydroxychloroquine is commonly used in the treatment of autoimmune diseases and may cause retinal toxicity with long-term use. OCTA is a non-invasive imaging modality that allows detailed assessment of retinal vascular changes.
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
OBSERVATIONAL
Enrollment
90
Start Date
2026-02-01
Completion Date
2026-09-01
Last Updated
2026-02-13
Healthy Volunteers
Yes